BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., announced today the successful closing of its acquisition of VerdaGenix, LLC, the owner and operator of the Ancient Extracts USA wellness platform. The transaction, which was executed under definitive documents finalized by both parties, makes Ancient Extracts USA a wholly owned subsidiary of BFCH, adding an established operating platform with direct-to-consumer infrastructure, commercial operations, proprietary formulations, and a catalog of over 20 wellness SKUs already in market.
Management views the acquisition as a pivotal step in the Company's evolution from a holding company into a scalable operating platform focused on wellness, performance, functional products, and human optimization. This development follows a series of strategic moves over the past year, including the elimination of more than $2 million in legacy convertible debt, strengthening of the balance sheet, restoration of disclosure compliance, and the acquisition of the EVERMIND™ intellectual property platform.
With the acquisition closed, BFCH is now transitioning Ancient Extracts into a phase of broader commercialization and expansion, targeting both DTC operations and retail distribution. The Company is advancing strategic growth capital initiatives to support inventory expansion, operational scaling, customer acquisition, and retail channel development. Management believes the deal de-risks the overall strategy by providing an active commercial foundation on which future growth can be accelerated.
John P. Gorst, CEO of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value."
Jordan P. Balencic, D.O., Chairman and Chief Science Officer, added: "Closing Ancient Extracts represents a transformational milestone for BFCH and UNLOCKD. We believe we are still in the early stages of building what can become a much larger operating platform centered around wellness, performance, functional products, cognitive health, and human optimization."
The Company also confirmed that management continues to evaluate additional acquisition opportunities, strategic partnerships, and commercialization initiatives aligned with its long-term strategy. Separately, BFCH received a formal legal opinion concluding that it is not a shell company under Rule 405 of the Securities Act of 1933, based on its operating strategy and asset base.
For more information, visit UNLOCKDinc.com and view current filings on OTC Markets.
